نمایش پرونده ساده آیتم

dc.contributor.authorEtemadi, J
dc.contributor.authorMajidi, T
dc.contributor.authorMotavalli, R
dc.contributor.authorBonyadi, M
dc.contributor.authorVahed, SZ
dc.contributor.authorZaker, B
dc.contributor.authorArdalan, M
dc.date.accessioned2018-08-26T09:01:15Z
dc.date.available2018-08-26T09:01:15Z
dc.date.issued2018
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/54988
dc.description.abstractBackground: Familial Mediterranean Fever (FMF) is the most common inherited autoinflammatory disease. Kidney involvement in FMF is usually attributed to secondary amyloidosis. Non-amyloid glomerular involvement has also been reported. Objectives: We suppose that heterozygous mutation of Mediterranean fever (MEFV) gene could be the underlying cause in some cases of mesangial proliferative glomerulonephritis (MePGN) in FMF endemic area. Materials and Methods: This prospective study was done between 2013 and 2015 in North- West of Iran among the Azari-Turkish population. A panel of MEFV gene including M680I, R761H, M694V, R408Q, E148Q, A744S, F479L, P369S, V726A, M694I, and E167D were studied in a group of patients with idiopathic MePGN. Clinical characteristics and therapeutic responses were compared between those with and without a mutation. A total of 39 idiopathic MePGN patients and 156 healthy subjects were studied. Results: Heterozygote mutations of MEFV gene were detected in 11/39 (28.2%) of MePGN patients and 46/156 (17.3%) of controls. Clinical response regarding 24 hours urine protein excretion was significant in mutation-negative patients after 6 months of follow-up. Conclusions: This study shows a possible underlying role of heterozygous MEFV gene mutation in the clinical course of some case of idiopathic MePGN, particularly in FMF endemic population. é 2018 The Author(s).
dc.language.isoEnglish
dc.relation.ispartofJournal of Nephropathology
dc.subjectangiotensin receptor antagonist
dc.subjectcorticosteroid
dc.subjectcyclosporine
dc.subjectdipeptidyl carboxypeptidase inhibitor
dc.subjectacute kidney failure
dc.subjectadult
dc.subjectaged
dc.subjectanalysis of variance
dc.subjectArticle
dc.subjectcohort analysis
dc.subjectcontrolled study
dc.subjectdeep vein thrombosis
dc.subjectdiabetes mellitus
dc.subjectdrug dose reduction
dc.subjectedema
dc.subjectendemic disease
dc.subjectevaluation and follow up
dc.subjectfamilial Mediterranean fever
dc.subjectfemale
dc.subjectgene
dc.subjectgene mutation
dc.subjectgenotype phenotype correlation
dc.subjecthepatitis
dc.subjectheterozygote
dc.subjecthuman
dc.subjectimmunofluorescence test
dc.subjectmajor clinical study
dc.subjectmale
dc.subjectMEFV gene
dc.subjectmiddle aged
dc.subjectpolymerase chain reaction
dc.subjectproliferative glomerulonephritis
dc.subjectprospective study
dc.subjectprotein urine level
dc.subjectproteinuria
dc.subjectqualitative analysis
dc.subjectreproducibility
dc.subjectrestriction fragment length polymorphism
dc.subjectretrospective study
dc.subjecturinalysis
dc.subjectyoung adult
dc.titleMediterranean fever gene mutations in patients with idiopathic mesangial proliferative glomerulonephritis
dc.typeArticle
dc.citation.volume7
dc.citation.issue2
dc.citation.spage45
dc.citation.epage50
dc.citation.indexScopus
dc.identifier.DOIhttps://doi.org/10.15171/jnp.2018.13


فایلهای درون آیتم

Thumbnail

این آیتم در مجموعه های زیر مشاهده می شود

نمایش پرونده ساده آیتم